Sentara Infusion Services: Drug Recall
Recall #D-0279-2023 · 12/27/2022
Class II: Risk
Recall Details
- Recall Number
- D-0279-2023
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- Sentara Infusion Services
- Status
- Completed
- Date Initiated
- 12/27/2022
- Location
- Chesapeake, VA, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 8 syringes
Reason for Recall
Lack of sterility assurance
Product Description
CEFAZOLIN 5mg/mL/HEPARIN 100unit/ml 1.5ML SYR, antibiotic, Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320
Distribution Pattern
Dispensed to Patients Nationwide.
Other Recalls by Sentara Infusion Services
- Class II: Risk 12/27/2022
- Class II: Risk 12/27/2022
- Class II: Risk 12/27/2022
- Class II: Risk 12/27/2022
- Class II: Risk 12/27/2022
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.